Candens Capital LLC, 10% Owner at ORCHID CELLMARK INC (ORCH), bought 189,839 shares at $2.07 ($400K) on 2006-08-01, disclosed to the SEC on 2006-08-03.
Open-market purchase of $400k ORCH by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.07 | 26,371 | $55K | 13.7% |
| 2 | $2.07 | 21,740 | $45K | 11.3% |
| 3 | $2.08 | 68,041 | $142K | 35.4% |
| 4 | $2.08 | 7,362 | $15K | 3.8% |
| 5 | $2.16 | 13,635 | $29K | 7.4% |
| 6 | $2.16 | 25,165 |
| $54K |
| 13.6% |
| 7 | $2.16 | 27,525 | $59K | 14.9% |
| Total | $2.11 avg | 189,839 | $400K | 100% |
| Filing → |
| GTS | BUY | 2008-10-24 | $471K | — | Filing → |
| EMAG | BUY | 2008-10-17 | $620K | — | Filing → |
| RURL | BUY | 2007-08-30 | $90K | — | Filing → |